LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer

Clinical trial NCT01015118 · COMPLETED

Trial details

NCT number: NCT01015118
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Neoplasms Peritoneal Neoplasms

Start date: 2009-11-17
Primary completion: 2013-04-01
Enrollment: 1366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.